6
452
M. Cheriyan et al. / Bioorg. Med. Chem. 19 (2011) 6447–6453
theory, this method could select for reaction of aldolases with any
unnatural aldehyde within the limits of solubility, chemical stabil-
ity, competing reactivity, and acute toxicity to the cell. It is clear
The PB25 strain is an E. coli K12 JM101-derived strain where the
pyruvate kinase genes, pykA and pykF, have been disrupted [supE
r
r
thi
were made according to the protocol described by Hanahan et al.
except that 0.2% glucose was added to the growth media to en-
hance growth of the auxtrophic cell line and stored in 80 L ali-
quots at ꢀ80 °C for up to 3 months. Electroporation of up to 1
of DNA was done using a BIORAD Gene Pulser in 0.1 mm cuvettes
D(lac-proAB) pykA::kan pykF::cat ]. Electrocompetent PB25 cells
31
M M
that significant improvements in K and kcat/K can be achieved
with a minimal number of mutations at sites that would not have
been identified a priori from protein structural data. However,
in vivo selections may not be optimal for generating improvements
in the turnover number (kcat) of an enzyme, as high substrate con-
centrations may not be readily achieved inside the cell. These find-
ings also point to one of the challenges of in vivo selections; the
overall fitness of the organism is a function of careful tuning of
expression levels and activity of multiple proteins.
l
l
g
3
1
under standard E. coli transformation conditions. The cells were
immediately resuspended in a total of 4 mL of SOC media and al-
lowed to recover for 1 h at 34 °C and 250 rpm. The cells were pel-
leted and resuspended in 4 mL of M9 media twice to remove trace
amounts of glucose before plating on selective minimal media.
Most of the selected mutants improve KHO catalysis by lower-
ing the K
concentration of KHO is low. As a result, these in vivo selections
mainly identify improvements in K until the value of K is com-
parable to the cellular concentration of the substrate. Beyond this
point further improvements in K will not increase the catalytic
M
parameter, suggesting that the cellular steady-state
5.2. Low expression KDPG aldolase vectors
M
M
Mutations were made in the lac promoter of the pUC plasmid
using site-directed mutagenesis. The ꢀ35 region was changed from
TTTACA to TTTCCA by whole plasmid PCR amplification using the
M
efficiency of the enzyme or viability of the cells; additional
improvements must derive from an increase in the value of the
turnover number. For biocatalyst development, the value of kcat
is arguably the most important kinetic parameter, so developing
methods to engineer enzymes with improved kcat is desirable.
The intracellular concentration of KHO is difficult to control; how-
ever the periplasmic influx of small molecules is generally unregu-
0
following primer and its reverse complement: 5 -GCACCCCAGGCTT
0
TCCACTTTATGC-3 . A single guanosine nucleotide was introduced
in the spacer region between ꢀ10 and ꢀ35 using the following primer
0
and its reverse complement: 5 -CACTTTATGCTGTCCGGCTCGTAT
0
GTTG-3 . A point deletion was made in the ꢀ35 region of the lac pro-
moter (TTTACA to TTACA) using the following primer and its reverse
2
9
0
0
lated and KHO concentrations in the periplasm should parallel
those in the medium. Therefore, localization of the selected en-
zyme to the periplasm may circumvent issues with substrate con-
centration. A key advantage of this approach would be that the
concentration of KHO can be directly controlled by the growth con-
ditions, presumably allowing for the rapid engineering of aldolases
complement; 5 -GCACCCCAGGCTTACACTTTATGC-3 . The PCR products
were transformed into SmartCells (Genlantis) using the standard heat
shock methods. Following overnight growth on LB agar plates con-
taining 100 lg/mL ampicillin (LB/AMP), a single colony was grown
up and the plasmid DNA was purified and sequenced.
The level of protein expression achieved by various plasmids
was determined by isolating PB25 cells that were transformed with
each plasmid. Ten large colonies were picked from LB/AMP and
with improved values of kcat
.
resuspended in 100
l
L
H
2
O
to
a
final concentration of
5
5
. Materials and methods
.1. Library creation
OD600 = 1.25. The cells were lysed by heating for 10 min at 95 °C
after addition of SDS loading dye. The cell debris was pelleted
and the supernatant was fractionated on a 12% polyacylamide
gel. The proteins were transferred electrophoretically to nitrocellu-
lose paper and blotted according to the manufacturer’s procedures
using Mouse anti-His antibody (Novagen) followed by Goat anti-
Mouse AP-conjugate secondary antibody (Novagen). The presence
of bound antibody was visualized by staining with 5-bromo-
Error prone PCR amplification of the T. maritima eda genes was
conducted using the Genemorph mutagenesis kit (Stratagene).
Primers containing SacI and XhoI restriction sites were used
0
(
forward 5 -GGAAACAGCTATGACCATGATTACGAATTCGAGCTCTAC
0
0
CATG-3 and reverse 5 -CTCAGTGGTGGTGGTGGTGGTGCTCGACT
TC -3 ). The eda genes were encoded on pUC derived plasmid TME-
0
0
4-chloro-3 -indolyphosphate p-toluidine and nitro-blue tetrazo-
DA-pUC as previously reported.14 Following PCR amplification, the
DNA was fractionated on a 1% agarose gel and extracted using
Microcon Ultrafree DA spin filters. The plasmid was simultaneously
digested with SacI and XhoI in NEB Buffer 4 and BSA (New England
BioLabs) and the DNA encoding the eda gene was purified on a 1%
agarose gel and extracted with phenol/chloroform followed by pre-
cipitation with ethanol using standard protocols.30 The vector for
ligation reactions was made by digestion of the original TMEDA-
pUC plasmid, (or reduced expression vectors described below) with
SacI and XhoI and purification on a gel followed by phenol:chloro-
form extraction. Ligations were run using a 1:1.2 molar excess of in-
lium chloride to detect phosphatase activity. The blot was
quantified using the Gel-Pro Analyzer software (Media Cybernet-
ics) to determine the level of expression.
5
.3. Selection conditions
Transformed cells were plated on selective M9 minimal media
that contained the following: 0.2% ribose, 1
g/mL proline, 50 g/mL carbenecillin, and 2.5 mM KHO. The
plates were further supplemented with 1 M FeCl , 50 M ZnSO
.1 M CaCl , 40 g/mL each adenosine, guanosine, thymidine,
cytosine and uracil, and 1 g/mL each of -biotin, cyanocobalamin,
folic acid, niacinamide, -pantothenate, pyridoxal hydrochloride
lg/mL thiamine,
4
0
l
l
l
3
l
4
,
0
l
2
l
l
D
sert to vector at 125 ng/lL total DNA concentration. T4 DNA Ligase
D
(
New England BioLabs) was used with the supplied buffer and
and riboflavin. These supplements improve the growth of the
PB25 strain on minimal plates without negating the pyruvate aux-
otroph phenotype. The library size was estimated by counting the
number of recovered colonies on LB plates containing carbenicillin.
Selection plates were grown at 34 °C.
1
0 mM ATP. Ligation reactions were incubated on ice overnight,
allowing the reaction to slowly reach room temperature. The prod-
uct DNA was extracted with phenol:chloroform and precipitated
with ethanol before resuspending in water to a final concentration
of 625 ng/
lL. The E.coli KDPG aldolase library was constructed
As controls, plasmids containing the wild-type aldolase genes
were transformed into PB25 cells and plated on selective media
alongside the libraries. No significant growth was seen on this
plate within 120 h. All colonies that grew in the first 120 h on
similarly to the TM library using the following primers: forward
0
0
5
-GAAAACAGCTATGACCATGATTACGAATTCGAGCTCGCTCATG-3 ;
0
0
reverse 5 -ATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTT-3 and the
pUC-ECEDA derived plasmid.14